ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 406 filers reported holding ENCOMPASS HEALTH CORP in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $532 | -35.7% | 7,920 | -35.2% | 0.05% | -49.0% |
| Q2 2023 | $827 | -61.4% | 12,220 | -69.2% | 0.10% | -47.5% |
| Q1 2023 | $2,144 | -99.6% | 39,639 | +434.2% | 0.20% | +266.7% |
| Q4 2021 | $484,000 | -44.9% | 7,420 | -36.6% | 0.05% | -48.6% |
| Q3 2021 | $878,000 | +278.4% | 11,700 | +293.9% | 0.10% | +356.5% |
| Q2 2021 | $232,000 | -54.2% | 2,970 | -51.5% | 0.02% | -72.0% |
| Q4 2020 | $507,000 | -50.4% | 6,130 | -62.8% | 0.08% | -46.8% |
| Q2 2020 | $1,022,000 | +81.9% | 16,500 | +103.3% | 0.15% | +71.1% |
| Q4 2019 | $562,000 | +77.3% | 8,116 | +62.2% | 0.09% | +69.8% |
| Q2 2019 | $317,000 | -5.4% | 5,005 | -12.7% | 0.05% | -3.6% |
| Q1 2019 | $335,000 | -66.5% | 5,733 | -64.6% | 0.06% | -68.2% |
| Q4 2018 | $999,000 | -22.4% | 16,194 | -1.9% | 0.17% | -3.4% |
| Q3 2018 | $1,287,000 | +273.0% | 16,510 | +224.1% | 0.18% | +244.2% |
| Q2 2018 | $345,000 | -14.2% | 5,094 | -27.5% | 0.05% | -13.3% |
| Q1 2018 | $402,000 | – | 7,023 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
| JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
| Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
| Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
| REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
| AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
| RK Capital | 179,800 | $13,492,000 | 2.55% |
| Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
| BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
| Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |